These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 25093734)

  • 21. Oncolytic gene therapy with recombinant vaccinia strain GLV-2b372 efficiently kills hepatocellular carcinoma.
    Ady JW; Johnsen C; Mojica K; Heffner J; Love D; Pugalenthi A; Belin LJ; Chen NG; Yu YA; Szalay AA; Fong Y
    Surgery; 2015 Aug; 158(2):331-8. PubMed ID: 26049609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of malignant effusion by oncolytic virotherapy in an experimental subcutaneous xenograft model of lung cancer.
    Weibel S; Hofmann E; Basse-Luesebrink TC; Donat U; Seubert C; Adelfinger M; Gnamlin P; Kober C; Frentzen A; Gentschev I; Jakob PM; Szalay AA
    J Transl Med; 2013 May; 11():106. PubMed ID: 23635329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Imaging characteristics, tissue distribution, and spread of a novel oncolytic vaccinia virus carrying the human sodium iodide symporter.
    Haddad D; Chen CH; Carlin S; Silberhumer G; Chen NG; Zhang Q; Longo V; Carpenter SG; Mittra A; Carson J; Au J; Gonen M; Zanzonico PB; Szalay AA; Fong Y
    PLoS One; 2012; 7(8):e41647. PubMed ID: 22912675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. VEGF-specific short hairpin RNA-expressing oncolytic adenovirus elicits potent inhibition of angiogenesis and tumor growth.
    Yoo JY; Kim JH; Kwon YG; Kim EC; Kim NK; Choi HJ; Yun CO
    Mol Ther; 2007 Feb; 15(2):295-302. PubMed ID: 17235307
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination treatment with oncolytic Vaccinia virus and cyclophosphamide results in synergistic antitumor effects in human lung adenocarcinoma bearing mice.
    Hofmann E; Weibel S; Szalay AA
    J Transl Med; 2014 Jul; 12():197. PubMed ID: 25030093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced antitumor efficacy of a novel oncolytic vaccinia virus encoding a fully monoclonal antibody against T-cell immunoglobulin and ITIM domain (TIGIT).
    Zuo S; Wei M; He B; Chen A; Wang S; Kong L; Zhang Y; Meng G; Xu T; Wu J; Yang F; Zhang H; Wang S; Guo C; Wu J; Dong J; Wei J
    EBioMedicine; 2021 Feb; 64():103240. PubMed ID: 33581644
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel oncolytic viral therapy and imaging technique for gastric cancer using a genetically engineered vaccinia virus carrying the human sodium iodide symporter.
    Jun KH; Gholami S; Song TJ; Au J; Haddad D; Carson J; Chen CH; Mojica K; Zanzonico P; Chen NG; Zhang Q; Szalay A; Fong Y
    J Exp Clin Cancer Res; 2014 Jan; 33(1):2. PubMed ID: 24383569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An oncolytic vaccinia virus armed with anti-human-PD-1 antibody and anti-human-4-1BB antibody double genes for cancer-targeted therapy.
    Shi Z; Liu B; Huang C; Xie W; Cen Y; Chen L; Liang M
    Biochem Biophys Res Commun; 2021 Jun; 559():176-182. PubMed ID: 33945995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lister vaccine strain of vaccinia virus armed with the endostatin-angiostatin fusion gene: an oncolytic virus superior to dl1520 (ONYX-015) for human head and neck cancer.
    Tysome JR; Wang P; Alusi G; Briat A; Gangeswaran R; Wang J; Bhakta V; Fodor I; Lemoine NR; Wang Y
    Hum Gene Ther; 2011 Sep; 22(9):1101-8. PubMed ID: 21361787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization and evaluation of a new oncolytic vaccinia virus strain LIVP6.1.1 for canine cancer therapy.
    Gentschev I; Patil SS; Adelfinger M; Weibel S; Geissinger U; Frentzen A; Chen NG; Yu YA; Zhang Q; Ogilvie G; Szalay AA
    Bioengineered; 2013; 4(2):84-9. PubMed ID: 23093804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. VEGF blockade enables oncolytic cancer virotherapy in part by modulating intratumoral myeloid cells.
    Currier MA; Eshun FK; Sholl A; Chernoguz A; Crawford K; Divanovic S; Boon L; Goins WF; Frischer JS; Collins MH; Leddon JL; Baird WH; Haseley A; Streby KA; Wang PY; Hendrickson BW; Brekken RA; Kaur B; Hildeman D; Cripe TP
    Mol Ther; 2013 May; 21(5):1014-23. PubMed ID: 23481323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regression of human pancreatic tumor xenografts in mice after a single systemic injection of recombinant vaccinia virus GLV-1h68.
    Yu YA; Galanis C; Woo Y; Chen N; Zhang Q; Fong Y; Szalay AA
    Mol Cancer Ther; 2009 Jan; 8(1):141-51. PubMed ID: 19139123
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oncolytic vaccinia virus demonstrates antiangiogenic effects mediated by targeting of VEGF.
    Hou W; Chen H; Rojas J; Sampath P; Thorne SH
    Int J Cancer; 2014 Sep; 135(5):1238-46. PubMed ID: 24474587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oncolytic vaccinia virus GLV-1h68 strain shows enhanced replication in human breast cancer stem-like cells in comparison to breast cancer cells.
    Wang H; Chen NG; Minev BR; Szalay AA
    J Transl Med; 2012 Aug; 10():167. PubMed ID: 22901246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The highly attenuated oncolytic recombinant vaccinia virus GLV-1h68: comparative genomic features and the contribution of F14.5L inactivation.
    Zhang Q; Liang C; Yu YA; Chen N; Dandekar T; Szalay AA
    Mol Genet Genomics; 2009 Oct; 282(4):417-35. PubMed ID: 19701652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Significant Growth Inhibition of Canine Mammary Carcinoma Xenografts following Treatment with Oncolytic Vaccinia Virus GLV-1h68.
    Gentschev I; Ehrig K; Donat U; Hess M; Rudolph S; Chen N; Yu YA; Zhang Q; Bullerdiek J; Nolte I; Stritzker J; Szalay AA
    J Oncol; 2010; 2010():736907. PubMed ID: 20631910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced tumor therapy using vaccinia virus strain GLV-1h68 in combination with a β-galactosidase-activatable prodrug seco-analog of duocarmycin SA.
    Seubert CM; Stritzker J; Hess M; Donat U; Sturm JB; Chen N; von Hof JM; Krewer B; Tietze LF; Gentschev I; Szalay AA
    Cancer Gene Ther; 2011 Jan; 18(1):42-52. PubMed ID: 20829890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polymeric Cups for Cavitation-mediated Delivery of Oncolytic Vaccinia Virus.
    Myers R; Coviello C; Erbs P; Foloppe J; Rowe C; Kwan J; Crake C; Finn S; Jackson E; Balloul JM; Story C; Coussios C; Carlisle R
    Mol Ther; 2016 Sep; 24(9):1627-33. PubMed ID: 27375160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new recombinant vaccinia with targeted deletion of three viral genes: its safety and efficacy as an oncolytic virus.
    Yang S; Guo ZS; O'Malley ME; Yin X; Zeh HJ; Bartlett DL
    Gene Ther; 2007 Apr; 14(8):638-47. PubMed ID: 17268533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Imaging of intratumoral inflammation during oncolytic virotherapy of tumors by 19F-magnetic resonance imaging (MRI).
    Weibel S; Basse-Luesebrink TC; Hess M; Hofmann E; Seubert C; Langbein-Laugwitz J; Gentschev I; Sturm VJ; Ye Y; Kampf T; Jakob PM; Szalay AA
    PLoS One; 2013; 8(2):e56317. PubMed ID: 23441176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.